Mark Wavrunek
Foot & Ankle Surgery · Quincy, ILNPI 1194107607
Payments from drug & device makers
Across 65 payments — averaging $137.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Elite Orthopedics, LLC$3K
- Stryker$988
- Paragon 28, Inc.$950
- Flower Orthopedics Coporation$149
- AbbVie$52
- plus $32 from 1 others
Across 2 payments — averaging $252.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$505
What the payments were for
- Travel & lodging$2,02423%
- Food & beverage$1,46716%
- Education$5,44661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 18 | $3,991 |
| Elite Orthopedics, LLC | 10 | $2,775 |
| Stryker(2 entities) | 26 | $988 |
| Paragon 28, Inc. | 6 | $950 |
| Flower Orthopedics Coporation | 1 | $149 |
| AbbVie | 3 | $52 |
| Summ Cott Medical | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,937 in reported general payments places this provider in the 80th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 14 | $776 |
| Cephalexin | 12 | $290 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $216 |
| Dexamethasone Sodium Phosphate | 13 | $127 |
| Meloxicam | 16 | $31 |
| Ondansetron Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Quincy
- Douglas PacaccioRockford$4.3M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.4M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$586K
- Brian BurgessNaperville$496K
- Kyle PearsonMorris$208K
- Stephanie OexemanChicago$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.